Moderator Commentary: Immunotherapy in Non-Small Cell Lung Cancer

preview_player
Показать описание
Mark A. Socinski, MD, describes the growing potential of immunotherapy in non-small cell lung cancer.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Moderator Commentary: Immunotherapy 0:04:44

Moderator Commentary: Immunotherapy in Non-Small Cell Lung Cancer

Advanced NSCLC: Refining 0:44:56

Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape

Introduction: Checkpoint Inhibition 0:12:33

Introduction: Checkpoint Inhibition in Non-Small Cell Lung Cancer

Novel Immunotherapy Combinations 0:07:00

Novel Immunotherapy Combinations in NSCLC

Immunotherapy: Simple in 0:10:44

Immunotherapy: Simple in Theory

Immunotherapy in the 1:00:33

Immunotherapy in the Metastatic Settings in Non-Small Cell Lung Cancer

Dr. Socinski on 0:01:40

Dr. Socinski on Immunotherapy Approaches in Squamous NSCLC

Immunotherapy for Lung 0:11:36

Immunotherapy for Lung Cancer: Currently Enrolling Clinical Trials of Combination Therapies

Cancer Immunotherapy Workshop 0:53:52

Cancer Immunotherapy Workshop 2021 – Moderated Open Discussion: Immune Effects by FUS Modality

Dr. Raffaele Califano 0:02:15

Dr. Raffaele Califano on Immunotherapy in Small Cell Lung Cancer

Applying Immunotherapy Learnings 0:02:44

Applying Immunotherapy Learnings in Melanoma to Lung Cancer

Introduction: Antibody-Based Cancer 0:07:58

Introduction: Antibody-Based Cancer Immunotherapy

Cellular immunotherapy for 0:01:54

Cellular immunotherapy for lung cancer

Marianne Davies on 0:02:00

Marianne Davies on Managing Immunotherapy Side Effects in Lung Cancer

Medicine Grand Rounds: 1:00:34

Medicine Grand Rounds: Immunotherapy in Lung Cancer 1/16/18

Cancer Immunotherapy Workshop 0:31:21

Cancer Immunotherapy Workshop 2021 –Moderated Open Discussion: Metrics to Predict Clinical Success

The Future of 0:55:31

The Future of Tumor Testing

First-line pembrolizumab plus 0:07:13

First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year fol...

Dr. Herbst on 0:01:56

Dr. Herbst on Advances of Immunotherapy in Lung Cancer

EGFR-Resistant Disease in 0:03:00

EGFR-Resistant Disease in Lung Cancer

Looking Ahead to 0:02:27

Looking Ahead to the Next Game-Changer in Lung Cancer

The Role of 0:00:57

The Role of Lenvatinib in NSCLC Treatment

Biologic basis of 0:20:48

Biologic basis of immunotherapy in lung cancer

Immunotherapy: Unleashing the 0:58:19

Immunotherapy: Unleashing the Body’s Natural Defense Systems to Fight Cancer